On Apr. 28, 2021, XPhyto announce that it has delivered 2,000 of its rapid 25-minute PCR tests (ﾓCovid-ID Labﾔ) to an established medical distributor in Israel for clinical evaluation of Covid-ID Lab for the purpose of commercial regulatory approval and potential product distribution.

The clinical evaluation process was expected to be completed in less than 90 days and will form the basis for commercial approval of Covid-ID Lab in Israel.